Karen L. Smith, Global Head of R&D and CMO at Jazz Pharmaceuticals plc (JAZZ), bought 1,216 shares at $137.10 ($167K) on 2016-08-12, disclosed to the SEC on 2016-08-12.
Recurring purchase ($167k) by Global Head of R&D and CMO following this insider's established cadence. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $137.10 | 607 | $83K | 49.9% |
| 2 | $137.10 | 607 | $83K | 49.9% |
| 3 | $137.26 | 1 | $137 | 0.1% |
| 4 | $137.26 | 1 | $137 | 0.1% |
| Total | $137.10 avg | 1,216 | $167K | 100% |
| Filing → |
| XLRN | SELL | 2021-04-02 | $2.4M | — | Filing → |
| JAZZ | BUY | 2016-07-13 | $167K | — | Filing → |
| JAZZ | BUY | 2016-06-15 | $167K | — | Filing → |